Cited by 277Lipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphismsLipid metabolism and disorders

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan: Marked Hyperalphalipoproteinemia Caused by CETP Gene Mutation Is Not Associated With Longevity

Hirano, Ken-ichi, Yamashita, Shizuya, Nakajima, Norimichi, Arai, Takeshi, Maruyama, Takao, Yoshida, Yu, Ishigami, Masato, Sakai, Naohiko, Kameda-Takemura, Kaoru, Matsuzawa, Yuji·1997·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.17.6.1053

Open this paper in CoChat — free account

Abstract

Abstract Low levels of HDL cholesterol have been clearly demonstrated to be associated with an increased incidence of coronary heart disease, strongly suggesting that HDL particles have an antiatherogenic function. However, little information has been available concerning the atherogenicity of a marked hyperalphalipoproteinemia (HALP). There is no agreement about whether plasma cholesteryl ester transfer protein (CETP) deficiency is associated with an antiatherogenic state or not, although this disorder was reported to be one of the major causes of marked HALP. In the current study, we have found a unique area (Omagari City, Akita Prefecture, Japan) where CETP deficiency caused by a G-to-A mutation at the 5′ splice donor site of intron 14 in the CETP gene is extremely frequent. In Omagari City, the mutation was detected more than 20 times more frequently and the prevalence of a marked HALP with plasma HDL cholesterol ≥2.58 mmol/L (100 mg/dL) was 5 to 10 times higher than in other areas of Japan. This discovery has made it possible to perform a large population-based study concerning the atherogenicity of a marked elevation of HDL cholesterol in a genetically more homogeneous population. There was a statistically significant U-shaped relationship between HDL cholesterol levels and the incidence of ischemic changes in electrocardiograms. In cases of HDL cholesterol <1.81 mmol/L (70 mg/dL), the incidence increased in proportion to the levels of HDL cholesterol. The frequency of the CETP gene mutation was higher in patients with coronary heart disease than in healthy control subjects. In subjects aged >80 years, the prevalence of both marked HALP and the intron 14 splicing defect was significantly lower than in the younger generation. The current study indicated for the first time that a marked HALP caused by CETP gene mutation may not represent a longevity syndrome, suggesting the importance of reevaluation of the clinical significance and pathophysiology of a marked HALP.

Integrity signals

Registry

Crossref · 10.1161/01.atv.17.6.1053

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 862
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
Brown, M. L., Inazu, A., Hesler, C. B., Agellon, L. B., Mann, C., Whitlock, M. E., Marcel, Y. L., Milne, R. W., Koizumi, J., Mabuchi, H., et al. (1989) · Nature · doi:10.1038/342448a0 · Cited by 470
Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial Hypercholesterolemia
Hobbs, H. H., Brown, M. S., Russell, D. W., Davignon, J., & Goldstein, J. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171204 · Cited by 301
Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.
Hayek, T., Masucci-Magoulas, L., Jiang, X. L., Walsh, A., Rubin, E. M., Breslow, J. L., & Tall, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118255 · Cited by 265
Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.
Reichl, D., & Miller, N. E. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.6.785 · Cited by 238

Show all 40 references

Research works printed but not linked: 9

10.1161/atv91.11.1.1988006 · DOI
10.1161/atvb.15.11.1849 · DOI
1978, Clin Chem, 24, 24
Hishinuma J. Municipal Life Tables 1990 . Health and Welfare Statistics Association; 1993:44-45.
1993, Hum Genet, 91, 13
10.1016/0002-9343(77)90874-9 · DOI · Paper page
10.1161/circ.88.6.8252679 · DOI
1995, Ann NY Acad Sci, 748, 606
1992, Arch Pathol Lab Med, 116, 831

Sorted by citations

Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tardif, J., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Rużyłło, W., Bachinsky, W., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 968
Cholesteryl Ester Transfer Protein
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 868
Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Self-citation
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
Zannis, V. I., Chroni, A., & Krieger, M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0030-4 · Cited by 404
The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
de la Llera-Moya, M., Drazul‐Schrader, D., Asztalos, B. F., Cuchel, M., Rader, D. J., & Rothblat, G. H. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.199158 · Cited by 385
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336
Reverse cholesterol transport and cholesterol efflux in atherosclerosis
Ohashi, R., Mu, H. H., Wang, X., Yao, Q., & Chen, C. (2005) · QJM · doi:10.1093/qjmed/hci136 · Cited by 336
Atheroprotective mechanisms of HDL
Stein, O., & Stein, Y. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00065-9 · Cited by 318
Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan
Dakeishi, M., Shioya, T., Wada, Y., Shindo, T., Otaka, K., Manabe, M., Nozaki, J., Inoue, S., & Koizumi, A. (2002) · Human Mutation · doi:10.1002/humu.10026 · Cited by 316
Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis
Rittershaus, C. W., MILLER, D. P., Thomas, L. J., Picard, M. D., Honan, C. M., Emmett, C. D., Pettey, C. L., Adari, H. Y., Hammond, R. A., Beattie, D. T., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2106 · Cited by 308
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins
Shah, P. K., Kaul, S., Nilsson, J. Å., & Cercek, B. (2001) · Circulation · doi:10.1161/hc4501.098468 · Cited by 298
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway
Matsuura, F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27602 · Cited by 296
Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
Borggreve, S. E., Vries, R. D., & Dullaart, R. P. F. (2003) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2003.01263.x · Cited by 277
A review of CETP and its relation to atherosclerosis
de Grooth, G. J., Klerkx, A. H. E. M., Stroes, E. S. G., Stalenhoef, A. F. H., Kastelein, J. J. P., & Kuivenhoven, J. A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400007-jlr200 · Cited by 264
Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene
Agerholm-Larsen, B., Nordestgaard, B. G., Steffensen, R., Jensen, G., & Tybjærg‐Hansen, A. (2000) · Circulation · doi:10.1161/01.cir.101.16.1907 · Cited by 267
PLASMA LIPID TRANSFER PROTEINS, HIGH-DENSITY LIPOPROTEINS, AND REVERSE CHOLESTEROL TRANSPORT
Bruce, C., Chouinard, R. A., & Tall, A. R. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.297 · Cited by 261
Beyond High-Density Lipoprotein Cholesterol Levels
deGoma, E. M., deGoma, R. L., & Rader, D. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.016 · Cited by 252
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly
Curb, J. D., Abbott, R. D., Rodríguez, B. L., Masaki, K., Chen, R., Sharp, D. S., & Tall, A. R. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300520-jlr200 · Cited by 228
Cholesteryl Ester Transfer Protein Corrects Dysfunctional High Density Lipoproteins and Reduces Aortic Atherosclerosis in Lecithin Cholesterol Acyltransferase Transgenic Mice
Föger, B., Chase, M. B., Amar, M. J., Vaisman, B. L., Shamburek, R. D., Paigen, B. J., Fruchart‐Najib, J., Paiz, J. A., Koch, C. A., Hoyt, R. F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.36912 · Cited by 224
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins
Shah, P. K., Kaul, S., Nilsson, J. Å., & Cercek, B. (2001) · Circulation · doi:10.1161/hc4401.098467 · Cited by 223
Increased Atherosclerosis in ApoE and LDL Receptor Gene Knock-Out Mice as a Result of Human Cholesteryl Ester Transfer Protein Transgene Expression
Plump, A. S., Masucci-Magoulas, L., Bruce, C., Bisgaier, C. L., Breslow, J. L., & Tall, A. R. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.1105 · Cited by 222
Lipoproteins, cholesterol homeostasis and cardiac health
Daniels, T. F., Killinger, K., Michal, J. J., Wright, R. W., & Jiang, Z. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.474 · Cited by 210
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
Hata, Y., Mabuchi, H., Saitō, Y., Itakura, H., Egusa, G., Ito, H., Teramoto, T., Tsushima, M., Tada, N., Oikawa, S., et al. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.1 · Cited by 188
Self-citation
A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein Deficiency
Moriyama, Y., Okamura, T., Inazu, A., Doi, M., Iso, H., Mouri, Y., Ishikawa, Y., Suzuki, H., Iida, M., Koizumi, J., et al. (1998) · Preventive Medicine · doi:10.1006/pmed.1998.0340 · Cited by 170
Where are we with probucol: A new life for an old drug?
Yamashita, S., & Matsuzawa, Y. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.002 · Cited by 171
Self-citation
Expression of Human Scavenger Receptor Class B Type I in Cultured Human Monocyte-Derived Macrophages and Atherosclerotic Lesions
Hirano, K., Yamashita, S., Nakagawa, Y., Ohya, T., Matsuura, F., Tsukamoto, K., Okamoto, Y., Matsuyama, A., Matsumoto, K., Miyagawa, J.-I., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.1.108 · Cited by 166
Self-citation
Cholesterol efflux pathways, inflammation, and atherosclerosis
Groenen, A. G., Halmos, B., Tall, A. R., & Westerterp, M. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1925217 · Cited by 175
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
Boekholdt, S. M., & Thompson, J. F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200018-jlr200 · Cited by 162
Novel HDL-directed pharmacotherapeutic strategies
deGoma, E. M., & Rader, D. J. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.200 · Cited by 149
Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH–JAPAN study
Hirata, A., Sugiyama, D., Watanabe, M., Tamakoshi, A., Iso, H., Kotani, K., Kiyama, M., Yamada, M., Ishikawa, S., Murakami, Y., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.014 · Cited by 150
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
Goff, W. L., Guérin, M., & Chapman, M. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.10.001 · Cited by 148
Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility
Guyard‐Dangremont, V., Desrumaux, C. M., Gambert, P., Lallemant, C., & Lagrost, L. (1998) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(98)10038-x · Cited by 138
Is raising HDL a futile strategy for atheroprotection?
JOY, T. R., & Hegele, R. A. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2489 · Cited by 139
Cholesterol metabolism: A review of how ageing disrupts the biological mechanisms responsible for its regulation
Morgan, A. E., Mooney, K. M., Wilkinson, S. J., Pickles, N. A., & Auley, M. T. M. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.008 · Cited by 145
The safety and immunogenicity of a CETP vaccine in healthy adults
Davidson, M. H., Maki, K. C., Umporowicz, D. M., Wheeler, A., Rittershaus, C. W., & Ryan, U. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00137-0 · Cited by 131
Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community
Vasan, R. S., Pencina, M. J., Robins, S. J., Zachariah, J. P. V., Jasuja, G. K., D’Agostino, R. B., & Ordovás, J. M. (2009) · Circulation · doi:10.1161/circulationaha.109.872705 · Cited by 128
GENETICS OF LIPOPROTEIN ABNORMALITIES ASSOCIATED WITH CORONARY HEART DISEASE SUSCEPTIBILITY
Breslow, J. L. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.233 · Cited by 128
Common Cholesteryl Ester Transfer Protein Mutations, Decreased HDL Cholesterol, and Possible Decreased Risk of Ischemic Heart Disease
Agerholm-Larsen, B., Tybjærg‐Hansen, A., Schnohr, P., Steffensen, R., & Nordestgaard, B. G. (2000) · Circulation · doi:10.1161/01.cir.102.18.2197 · Cited by 130
The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population
Okamura, T., Hayakawa, T., Kadowaki, T., Kita, Y., Okayama, A., & Ueshima, H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.042 · Cited by 123
Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
Yamashita, S., Hirano, K., Sakai, N., & Matsuzawa, Y. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00164-5 · Cited by 123
Self-citation
An Increased Coronary Risk Is Paradoxically Associated with Common Cholesteryl Ester Transfer Protein Gene Variations That Relate to Higher High-Density Lipoprotein Cholesterol: A Population-Based Study
Borggreve, S. E., Hillege, H. L., Wolffenbuttel, B. H. R., de Jong, P. E., Zuurman, M. W., van der Steege, G., van Tol, A., & Dullaart, R. P. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2322 · Cited by 121
Inherited disorders of HDL metabolism and atherosclerosis
Hovingh, G. K., de Groot, E., van der Steeg, W. A., Boekholdt, S. M., Hutten, B. A., Kuivenhoven, J. A., & Kastelein, J. J. P. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162318.47172.ef · Cited by 115
HDL Biogenesis, Remodeling, and Catabolism
Zannis, V. I., Fotakis, P., Κούκος, Γ., Kardassis, D., Ehnholm, C., Jauhiainen, M., & Chroni, A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_2 · Cited by 123
Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
Yamashita, S., Bujo, H., Arai, H., Harada-Shiba, M., Matsui, S., Fukushima, M., Saito, Y., Kita, T., & Matsuzawa, Y. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e610 · Cited by 110
Self-citation
Molecular Mechanisms of Cholesteryl Ester Transfer Protein Deficiency in Japanese
Nagano, M., Yamashita, S., Hirano, K., Takano, M., Maruyama, T., Ishihara, M., Sagehashi, Y., Kujiraoka, T., Tanaka, K., Hattori, H., et al. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.110 · Cited by 107
Self-citation
Molecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions
Yamashita, S., Tsubakio‐Yamamoto, K., Ohama, T., Nakagawa-Toyama, Y., & Nishida, M. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5405 · Cited by 106
Self-citation
Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency
Asztalos, B. F., Horvath, K. V., Kajinami, K., Nartsupha, C., Cox, C. E., Batista, M. C., Schaefer, E. J., Inazu, A., & Mabuchi, H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300198-jlr200 · Cited by 98
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
Yamashita, S., Maruyama, T., Hirano, K., Sakai, N., Nakajima, N., & Matsuzawa, Y. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00574-8 · Cited by 97
Self-citation
The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease
Brewer, H. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0163 · Cited by 96
HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics
Vitali, C., Khetarpal, S. A., & Rader, D. J. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0940-0 · Cited by 96
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease
Nomura, A., Won, H., Khera, A. V., Takeuchi, F., Ito, K., McCarthy, S., Emdin, C. A., Klarin, D. M., Natarajan, P., Zekavat, S. M., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311145 · Cited by 86
Pros and cons of inhibiting cholesteryl ester transfer protein
Hirano, K., Yamashita, S., & Matsuzawa, Y. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00004 · Cited by 85
Self-citation
The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia
de Grooth, G. J., Smilde, T. J., van Wissen, S., Klerkx, A. H. E. M., Zwinderman, A. H., Fruchart, J., Kastelein, J. J. P., Stalenhoef, A. F. H., & Kuivenhoven, J. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.020 · Cited by 85
CETP Inhibition: Past Failures and Future Hopes
Kosmas, C. E., DeJesus, E., Rosario, D., & Vittorio, T. J. (2016) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s32667 · Cited by 80
High Density Lipoproteins in Health and in Disease
Genest, J. J., Marcil, M., Denis, M., & Yu, L. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700106 · Cited by 80
Increasing High-Density Lipoprotein Cholesterol in Dyslipidemia by Cholesteryl Ester Transfer Protein Inhibition
Forrester, J. S., Makkar, R., & Shah, P. K. (2005) · Circulation · doi:10.1161/01.cir.0000160860.36911.bd · Cited by 80
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides
Borggreve, S. E., Hillege, H. L., Dallinga‐Thie, G. M., de Jong, P. E., Wolffenbuttel, B. H. R., Grobbee, D. E., van Tol, A., Dullaart, R. P. F., & on behalf of the PREVEND Study Group (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm062 · Cited by 78
Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
Mabuchi, H., Nohara, A., & Inazu, A. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.0265 · Cited by 75
Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia
Maruyama, T., Sakai, N., Ishigami, M., Hirano, K., Arai, T., Okada, S., Okuda, E., Ohya, A., Nakajima, N., Kadowaki, K., et al. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00327-1 · Cited by 69
Self-citation
Cholesteryl ester transfer protein and its plasma regulator
Morton, R. E. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199908000-00006 · Cited by 70
Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: High-throughput assay by Invader® assay
Nagano, M., Yamashita, S., Hirano, K., Ito, M., Maruyama, T., Ishihara, M., Sagehashi, Y., Oka, T., Kujiraoka, T., Hattori, H., et al. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200024-jlr200 · Cited by 69
Self-citation
Mechanisms of Disease: HDL metabolism as a target for novel therapies
Rader, D. J. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0768 · Cited by 67
Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk
Pahor, M., Elam, M. B., Garrison, R. J., Kritchevsky, S. B., & Applegate, W. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.237 · Cited by 67
CETP gene variation: relation to lipid parameters and cardiovascular risk
Boekholdt, S. M., Kuivenhoven, J. A., Hovingh, G. K., Jukema, J. W., Kastelein, J. J. P., & van Tol, A. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137226.54278.60 · Cited by 66
Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men
Kakko, Tamminen, Päivänsalo, Kauma, Rantala, Lilja, Reunanen, Kesäniemi, & Savolainen (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00595.x · Cited by 65
Genetic variation in aldehyde dehydrogenase 2 and the effect of alcohol consumption on cholesterol levels
Nakamura, Y., Amamoto, K., Tamaki, S., Okamura, T., Tsujita, Y., Ueno, Y., Kita, Y., Kinoshita, M., & Ueshima, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00059-x · Cited by 64
The Pharmacology and Off-Target Effects of Some Cholesterol Ester Transfer Protein Inhibitors
Vergeer, M., & Stroes, E. S. G. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.09.017 · Cited by 63
The −629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men
Eiríksdóttir, G., Bolla, M. K., Thorsson, B., Sigurðsson, G., Humphries, S. E., & Gudnason, V. G. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00489-0 · Cited by 63
Epidemiological aspects of high density lipoprotein cholesterol1Presented at the 68th meeting of the European Atherosclerosis Society, Brugge, 8–10 May, 1997.1
Backer, G. D., Bacquer, D. D., & Kornitzer, M. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00310-9 · Cited by 62
ATP-Binding Cassette Transporter-1 Induces Rearrangement of Actin Cytoskeletons Possibly through Cdc42/N-WASP
Tsukamoto, K., Hirano, K., Tsujii, K., Ikegami, C., Zhongyan, Z., Nishida, Y., Ohama, T., Matsuura, F., Yamashita, S., & Matsuzawa, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5575 · Cited by 61
Self-citation
Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese
Hsu, L., Ko, Y., Hsu, K., Ko, Y.-H., & Lee, Y. (2001) · Human Genetics · doi:10.1007/s00439-001-0640-z · Cited by 60
Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport
Zhang, Z., Yamashita, S., Hirano, K., Nakagawa-Toyama, Y., Matsuyama, A., Nishida, M., Sakai, N., Fukasawa, M., Arai, H., Miyagawa, J., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00490-7 · Cited by 62
Self-citation
Cholesteryl ester transfer protein and atherosclerosis
Inazu, A., Koizumi, J., & Mabuchi, H. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200008000-00008 · Cited by 58
Aging and HDL Metabolism in Elderly People More Than 100 Years Old
Arai, Y., & Hirose, N. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.246 · Cited by 57
Risk Factors of Atherosclerotic Diseases - Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
Teramoto, T., Sasaki, J., Ueshima, H., Egusa, G., Kinoshita, M., Shimamoto, K., Daida, H., Biro, S., Hirobe, K., Funahashi, T., et al. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e578 · Cited by 57
Familial Dyslipidaemias
Hachem, S. B., & Mooradian, A. D. (2006) · Drugs · doi:10.2165/00003495-200666150-00005 · Cited by 60
Cholesteryl ester transfer protein: The controversial relation to atherosclerosis and emerging new biological roles
Oliveira, H. C. F., & de Faria, E. C. (2011) · IUBMB Life · doi:10.1002/iub.448 · Cited by 57
CETP inhibition in cardiovascular risk management: a critical appraisal
Dullaart, R. P. F., Dallinga‐Thie, G. M., Wolffenbuttel, B. H. R., & van Tol, A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01756.x · Cited by 54
Human genetics of HDL: Insight into particle metabolism and function
Brunham, L. R., & Hayden, M. R. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.001 · Cited by 54
Did we abandon probucol too soon?
Yamashita, S., Masuda, D., & Matsuzawa, Y. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000199 · Cited by 53
Self-citation
HDL-cholesterol: Is it really good?
Santos‐Gallego, C. G., Ibáñez, B., & Badimón, J. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.04.020 · Cited by 54
Common Variation in the CETP Gene and the Implications for Cardiovascular Disease and its Treatment: An Updated Analysis
Dullaart, R. P. F., & Sluiter, W. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.6.747 · Cited by 52
Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography
Goto, A., Sasai, K., Suzuki, S., Fukutomi, T., Ito, S., Matsushita, T., Okamoto, M., Suzuki, T., Itoh, M., Okumura‐Noji, K., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00476-2 · Cited by 52
Current Awareness
Roth, J. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200007/08)16:4
ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
Escolá‐Gil, J. C., Julve, J., Marzal-Casacuberta, À., Ordóñez‐Llanos, J., González‐Sastre, F., & Blanco‐Vaca, F. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31685-0 · Cited by 51
Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism
Niesor, E. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283475e00 · Cited by 47
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
Salazar, J. J., Olivar, L. C., Ramos, E., Chávez-Castillo, M., Rojas, J., & Bermúdez, V. (2015) · Cholesterol · doi:10.1155/2015/296417 · Cited by 50
Cholesteryl ester transfer protein, high density lipoprotein and arterial disease
Barter, P. J., & Rye, K. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00002 · Cited by 48
Phenotypes and Genotypes of High Density Lipoprotein Cholesterol in Exceptional Longevity
Milman, S., Atzmon, G., Crandall, J. P., & Barzilai, N. (2013) · Current Vascular Pharmacology · doi:10.2174/1570161111666131219101551 · Cited by 46
A Prospective Study of High-Density Lipoprotein Cholesterol, Cholesteryl Ester Transfer Protein Gene Variants, and Healthy Aging in Very Old Japanese-American Men
Koropatnick, T. A., Kimbell, J., Chen, R., Grove, J., Donlon, T. A., Masaki, K., Rodríguez, B. L., Willcox, B. J., Yano, K., & Curb, J. D. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.11.1235 · Cited by 46
Lipoprotein profile and cholesteryl ester transfer protein in neonates
Kaser, S., Ebenbichler, C. F., Wolf, H. J., Sandhofer, A., Stanzl, U., Ritsch, A., & Patsch, J. R. (2001) · Metabolism · doi:10.1053/meta.2001.23307 · Cited by 46
Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America
Teh, E., Dolphin, P. J., Breckenridge, W. C., & Tan, M.-H. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33905-5 · Cited by 45
Human genetics of variation in high-density lipoprotein cholesterol
Qasim, A., & Rader, D. J. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0074-0 · Cited by 43
Roles of plasma lipid transfer proteins in reverse cholesterol transport
Yamashita, S. (2001) · Frontiers in bioscience · doi:10.2741/a616 · Cited by 43
Self-citation
HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease
Brewer, H. B. (2007) · Current Cardiology Reports · doi:10.1007/bf02938393 · Cited by 42
Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in J774 macrophage
Kobayashi, J., Okamoto, H., OTABE, M., Bujo, H., & Saitō, Y. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00705-5 · Cited by 41
Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity
Arai, Y., Hirose, N., Yamamura, K., Nakazawa, S., Shimizu, K.-I., Takayama, M., Ebihara, Y., Homma, S., Gondo, Y., Masui, Y., et al. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0407-6 · Cited by 41
Optimal Management of Combined Dyslipidemia: What Have We Behind Statins Monotherapy?
Tenenbaum, A., Fisman, E. Z., Motro, M., & Adler, Y. (2008) · Advances in cardiology · doi:10.1159/000115192 · Cited by 38
Cholesteryl ester transfer protein and its inhibition
Weber, O., Bischoff, H., Schmeck, C., & Böttcher, M.-F. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0418-3 · Cited by 38
Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease
McCaskie, P. A., Beilby, J. P., Chapman, C., Hung, J., McQuillan, B., Thompson, P. L., & Palmer, L. J. (2007) · Human Genetics · doi:10.1007/s00439-007-0326-2 · Cited by 38

Authors: Hirano, K.-I., Yamashita, S., Nakajima, N., Arai, T., Maruyama, T., Yoshida, Y., Ishigami, M., Sakai, N., Kameda-Takemura, K., & Matsuzawa, Y.
Affiliations: The University of Osaka (JP)
From the Second Department of Internal Medicine, Osaka University Medical School (K-i.H., S.Y., T.A., T.M., Y.Y., M.I., N.S., K.K.-T., Y.M.), and the Nakajima Clinic, Akita (N.N.), Japan.
ORCID: Hirano, Ken-ichi
Yamashita, Shizuya
Arai, Takeshi
Maruyama, Takao
Yoshida, Yu
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1997-06
Volume: 17
Issue: 6
Pages: 1053-1059
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.17.6.1053
OpenAlex: W2151720705
Cited by: 275
References: 40
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 11 · 2014: 9 · 2013: 11 · 2012: 15
FWCI: 14.93
Type: journal article
Language: en
Open access: closed
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: hyperalphalipoproteinemia, HDL cholesterol, coronary artery disease, atherogenicity, genetic prevalence
MeSH terms: Aged, Carrier Proteins, Female, Glycoproteins, Humans, Japan, Lipid Metabolism, Inborn Errors, Lipoproteins, HDL, Longevity, Male, Middle Aged, Cholesterol Ester Transfer Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan: Marked Hyperalphalipoproteinemia Caused by CETP Gene Mutation Is Not Associated With Longevity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks